GleamWall
中文EN

CERS CERUS CORP

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1020214 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY54.2%
TTM EPS YoY50.0%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin-1.0%
Net margin-2.9%
FCF margin0.2%
EBITDA margin-0.3%

Returns

ROE-10.7%
ROA-3.5%
ROIC (approx.)-3.8%
Asset turnover1.21x

Leverage & solvency

Liabilities / assets62.7%
Debt / equity0.00x
Current ratio1.96x
Interest coverage-0.36x

Cash quality & payout

Operating cash flow / net income-0.48x
Accruals ratio-5.1%
Payout ratio—
Capex / revenue1.2%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$233.80M$201.32M
R&D expense$67.72M$58.91M
SG&A expense$80.91M$75.89M
Operating income-$8.68M-$14.22M
Interest expense$8.34M$8.88M
Pretax income-$15.28M-$20.76M
Income tax$354,000$205,000
Net income-$15.63M-$20.92M
EBITDA-$7.25M-$12.37M
EPS (basic)-0.08-0.11
EPS (diluted)-0.08-0.11
Weighted avg. shares (diluted)190.59M184.56M
Balance sheet
Cash & equivalents$19.96M$21.36M
Short-term investments$62.92M$60.19M
Receivables$30.37M$29.78M
Inventory$56.10M$38.15M
Current assets$174.38M$152.02M
PP&E, net$9.20M$7.15M
Goodwill$1.32M$1.32M
Total assets$221.86M$200.92M
Current liabilities$100.80M$63.61M
Total liabilities$156.89M$144.02M
Shareholders' equity$64.22M$56.15M
Shares outstanding192.14M185.77M
Cash flow statement
Operating cash flow$4.84M$11.36M
Capital expenditure$3.73M$2.84M
Free cash flow$1.11M$8.52M
Investing cash flow-$6.17M-$8.13M
Financing cash flow$231,000$4.96M
Depreciation & amortization$1.43M$1.85M
Stock-based compensation$22.87M$22.87M

Free plan shows the latest 2 periods; Pro shows all 17 🔒

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.